Several mechanisms can lead to chemotherapy resistance. One common mechanism is the overexpression of efflux pumps, such as P-glycoprotein, which actively transport chemotherapy drugs out of the cancer cells, reducing intracellular drug concentration. Another mechanism involves alterations in the drug targets, such as mutations in the genes encoding the target proteins, which reduce the drug's binding affinity and efficacy.
